Expression of circulating microRNAs in patients with ST segment elevation acute myocardial infarction

Minerva Cardioangiologica

Volumn 63, Issue 5, 2015, Pages 397-402

  Ji, Q ^a   Jiang, Q ^b   Yan, W ^b   Li, X ^a   Zhang, Y ^a   Meng, P ^a   Shao, M ^a   Chen, L ^a   Zhu, H ^a   Tian, N ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b First People's Hospital of Anqing in Anhui Province   (China)

Author keywords

Biological markers; MicroRNAs; Myocardial infarction

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 133A; MICRORNA 133B; MICRORNA 499 5P; RNA DIRECTED DNA POLYMERASE; TROPONIN; UNCLASSIFIED DRUG; MIRN133 MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN; TROPONIN I;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC MARKER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NORMAL HUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROFLUOROMETRY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; AGED; BLOOD; CASE CONTROL STUDY; CHINA; EARLY DIAGNOSIS; GENETICS; MYOCARDIAL INFARCTION; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHINA; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTORS; TROPONIN I;

EID: 84992169481     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
2. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011;124:1936-44.
3. Wang R, Li N, Zhang Y, Ran Y, Pu J. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med 2011;50:1789-95.
4. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010;31:2765-73.
5. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011;51:872-5.
6. Gidlof O, Andersson P, van der Pals J, Götberg M, Erlinge D. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with st elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 2011;118:217-26.
7. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 2011;4:446-54.
8. Olivieri F, Antonicelli R, Lorenzi M, D'Alessandra Y, Lazzarini R, Santini G et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol 2013;167:531-6.
9. Fichtlscherer S, De Rosa S, Fox H et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010; 107:677-84.
10. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010;106:1035-9.
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-8.
12. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N et al: Serum microRNAs are promising novel biomarkers. PLoS One 2008;3:e3148.
13. Han M, Toli J, Abdellatif M. MicroRNAs in the cardiovascular system. Curr Opin Cardiol 2011;26:181-9.
14. Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011;109:880-93.
15. Shieh JT, Huang Y, Gilmore J, Srivastava D. Elevated miR-499 levels blunt the cardiac stress response. PLoS One 2011;6:e19481.
16. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009;17:662-73.
17. Kim HJ, Cui XS, Kim EJ, KimWJ, KimNH. New porcine microRNA genes found by homology search. Genome 2006;49:1283-6.
18. Wang JX, Jiao JQ, Li Q, Long B, Wang K, Liu JP et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 2011;17:71-8.
19. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010;3: 499-506.
20. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010;31: 659-66.